ExanthemaDiaper RashDrug EruptionsAcneiform EruptionsDisease OutbreaksPurpuraMeaslesHerpes ZosterSkin DiseasesErythemaAlphavirus InfectionsQuinazolinesErythema InfectiosumDrug HypersensitivityCarcinogenicity TestsFeverChickenpoxHerpesvirus 3, HumanChikungunya virusTime FactorsTreatment OutcomeDermatitisNeuralgia, PostherpeticDisease Transmission, InfectiousStevens-Johnson SyndromeRubellaGenes, rasAnti-Bacterial AgentsMeasles VaccineSkin Diseases, ViralAntineoplastic AgentsZoster Sine HerpeteMeasles virusAntibodies, ViralPhylogenyTravelSkinMolecular Sequence DataChickenpox VaccinePruritusSmallpoxCommunicable Diseases, EmergingProtein Kinase InhibitorsRickettsia InfectionsMonkeypox virusDrug Administration ScheduleVirus ReplicationFolliculitisDermatomyositisAntibodies, Monoclonal, HumanizedParvovirus B19, HumanReceptor, Epidermal Growth FactorUrticariaDrug Hypersensitivity SyndromeDermatitis HerpetiformisFatal OutcomePolymerase Chain ReactionEpidemicsSyndromeAntibodies, MonoclonalHerpesvirus 6, HumanNeoplasmsSkin ManifestationsCross InfectionCarbamazepineLung NeoplasmsSequence Analysis, DNANeoplasm MetastasisIntroduced SpeciesScabiesNevirapineGeographyAdministration, OralMutationGenotypeParvoviridae InfectionsImmunoglobulin MMolecular EpidemiologyInfluenza, HumanHerpes Zoster OticusMaximum Tolerated DoseDengueModels, BiologicalCandidiasis, CutaneousErythema MultiformeMorbillivirusAntiviral AgentsElectrophoresis, Gel, Pulsed-FieldAnticonvulsantsDermatologyHIV InfectionsRetrospective StudiesDrug Therapy, CombinationTriazinesDermatitis, ExfoliativeScrub TyphusDose-Response Relationship, DrugSkin Diseases, InfectiousPhenylurea CompoundsNiacinamide